EUVIMEDEUVIMED entdecken
Vergleichsstudie

Seroprevalence of Hepatitis E Virus Infection among Blood Donors in Lebanon: A National Comparative Evaluation of Two Serological Assays

Elissa Massihy, Tamima Jisr, Rita Feghali, Elie Khoury, Walid Mahmoud, Rami Mahfouz, Daniel Candotti iD, Wael Dimassi, Elias Abdo, Mira El Chaar iD

Journal of Medical Virology · 2026-03 · 98 (3)

DOI: 10.1002/jmv.70857 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Medical Virology, online erschienen am 25.02.2026. Verfasst von Elissa Massihy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, University of Balamand, Beirut, Lebanon. Hauptthemen laut MEDLINE: Hepatitis E, Blood Donors, Hepatitis E virus, Hepatitis Antibodies. Die Arbeit nennt 61 Literaturangaben. Gefördert von: University of Balamand, Roche Diagnostics International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis E virus (HEV) is an emerging transfusion‐transmissible pathogen, yet epidemiological data from the Middle East remain limited, and differences in serological assay performance complicate interpretation of seroprevalence. Lebanon lacks national HEV surveillance data and has no blood donor screening policy. In this cross‐sectional national study, 3000 blood donors from all Lebanese governorates (July 2023–August 2024) were screened for anti‐HEV IgG and IgM using two commercial platforms: Euroimmun ELISA and Roche Elecsys electrochemiluminescence immunoassay (ECLIA). This study represents the first large‐scale, peer‐reviewed evaluation of the Roche Elecsys Anti‐HEV assays in a national blood donor population. All samples that were positive or borderline by either serological assay were tested for HEV RNA using real‐time RT‐PCR (Altona RealStar® and Roche Cobas®). Anti‐HEV IgG seroprevalence differed significantly between assays (Euroimmun: 1.13% vs. Roche Elecsys: 1.93%; p < 0.001). IgM prevalence was 0.07% and 0.33%, respectively. Overall agreement between assays was high (IgG: 98.7%; IgM: 99.7%), although Cohen's κ indicated limited concordance, with Roche Elecsys identifying additional low‐reactivity seropositive donors. Seropositivity varied across regions, with higher rates observed in South Lebanon (4.0%) and North Lebanon (3.1%). HEV RNA was not detected in any tested donor. HEV exposure among Lebanese blood donors is low but geographically distributed. Seroprevalence estimates were strongly assay‐dependent, indicating that HEV burden may be underestimated when lower‐sensitivity platforms are used. These findings highlight the importance of assay selection in HEV epidemiological studies and support consideration of selective HEV nucleic acid testing for high‐risk recipients to inform evidence‐based blood safety policy in Lebanon.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis EBlood DonorsHepatitis E virusHepatitis AntibodiesSerologic TestsHumansLebanonSeroepidemiologic StudiesImmunoglobulin GImmunoglobulin MCross-Sectional StudiesFemaleAdultMaleEnzyme-Linked Immunosorbent AssayRNA, ViralMiddle AgedYoung AdultBlood DonationAdolescent

Stichwörter der Autor:innen

ELISAElecsysEuroimmunHEVLebanonblood donorsblood safetyseroprevalence

Substanzen

Immunoglobulin GImmunoglobulin MHepatitis AntibodiesRNA, Viral

Autor:innen und Institutionen

  • Faculty of Health Sciences, University of Balamand, Beirut, Lebanon.
  • Clinical Laboratory Department, Makassed General Hospital, Beirut, Lebanon.
  • Department of Laboratory Medicine, Lebanese American University Gilbert and Rose Marie Chagoury School of Medicine, Byblos, Lebanon.
  • Lebanese Red Cross, Beirut, Lebanon.
  • Clinical Laboratory Department, Bhannes Hospital Center, Mount Lebanon, Lebanon.
  • Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.

ORCID-Profile: Daniel Candotti, Mira El Chaar

Förderung

  • University of Balamand
  • Roche Diagnostics International

Zitieren

APA

Massihy, E., Jisr, T., Feghali, R., Khoury, E., Mahmoud, W., Mahfouz, R., Candotti, D., Dimassi, W., Abdo, E., & Chaar, M. E. (2026). Seroprevalence of Hepatitis E Virus Infection among Blood Donors in Lebanon: A National Comparative Evaluation of Two Serological Assays. Journal of Medical Virology, 98(3). https://doi.org/10.1002/jmv.70857

Vancouver

Massihy E, Jisr T, Feghali R, Khoury E, Mahmoud W, Mahfouz R, et al. Seroprevalence of Hepatitis E Virus Infection among Blood Donors in Lebanon: A National Comparative Evaluation of Two Serological Assays. Journal of Medical Virology. 2026;98(3). doi:10.1002/jmv.70857

BibTeX
@article{Massihy2026,
  author = {Massihy, Elissa and Jisr, Tamima and Feghali, Rita and Khoury, Elie and Mahmoud, Walid and Mahfouz, Rami and Candotti, Daniel and Dimassi, Wael and Abdo, Elias and Chaar, Mira El},
  title = {Seroprevalence of Hepatitis E Virus Infection among Blood Donors in Lebanon: A National Comparative Evaluation of Two Serological Assays},
  journal = {Journal of Medical Virology},
  year = {2026},
  volume = {98},
  number = {3},
  doi = {10.1002/jmv.70857}
}
Kostenlos starten →